You are here

  • Home
  • Archive
  • Volume 14, Issue 2
  • Long-term follow-up of a phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer in the Southwest Oncology Group

Article metrics

Article menu
Download PDFPDF
ORIGINAL ARTICLES
Long-term follow-up of a phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer in the Southwest Oncology Group

 

Online download statistics by month:

Online download statistics by month: March 2019 to September 2024

AbstractFullPdf
Mar 20191600
Apr 20191400
May 20191001
Jun 2019800
Jul 2019400
Aug 2019700
Sep 2019400
Oct 2019400
Nov 2019500
Dec 2019400
Jan 20201400
Feb 2020900
Mar 2020200
Apr 2020600
May 20201400
Jun 2020600
Jul 20201400
Aug 20201100
Sep 2020700
Oct 20204500
Nov 20209000
Dec 20202302
Jan 20211400
Feb 2021100
Mar 2021600
Apr 2021500
May 2021300
Jun 2021100
Aug 2021100
Sep 2021200
Oct 20211000
Nov 2021300
Dec 20211000
Jan 20222500
Feb 20222100
Mar 20221600
Apr 20221300
May 20223400
Jun 20224000
Jul 20221300
Aug 20223700
Sep 20223400
Oct 20223400
Nov 20221700
Dec 20221401
Jan 20231300
Feb 20237200
Mar 20232500
Apr 20235700
May 2023500
Jun 2023200
Jul 2023400
Aug 20231000
Sep 20234802
Oct 20231600
Nov 20231300
Dec 20231900
Jan 20241300
Feb 2024400
Mar 2024700
Apr 20242501
May 20242300
Jun 20242100
Jul 20241400
Aug 20242201
Sep 20241500
Total109908